23andMe's aim: Getting customers drugs developed with their data - STAT

23andMe's aim: Getting customers drugs developed with their data - STAT

23andMe’s next challenge: ensuring its customers can get drugs developed with their data

By KATE SHERIDAN

EMMA MCINTYRE/GETTY IMAGES FOR MAKERS

GlaxoSmithKiline's drug-development partnership with 23andMe "can double the probability of success,” said GSK’s chief scientific officer.

READ MORE